Related references
Note: Only part of the references are listed.Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2010)
Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery
Maria T. Sandri et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
Circulating tumor cells and emerging blood biomarkers in breast cancer
Carmen Criscitiello et al.
CURRENT OPINION IN ONCOLOGY (2010)
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
Julie E. Lang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Systemic spread is an early step in breast cancer
Yves Huesemann et al.
CANCER CELL (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
Statistical considerations for enumeration of circulating tumor cells
Arjan G. J. Tibbe et al.
CYTOMETRY PART A (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
Erich F. Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients
P Wülfing et al.
CLINICAL CANCER RESEARCH (2006)
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer
K Pachmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol
R Leake et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
